SCHEMBL28064203

SCHEMBL28064203

O=C(Cc1cncs1)ON1CCC(CCOc2cc(Cl)ccc2Cl)CC1

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PPARG P37231 9/20 0.46
PPARD Q03181 9/20 0.46
PPARA Q07869 6/20 0.46
GRM5 P41594 1/20 0.40
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTR7 P34969 2/20 0.38
F10 P00742 4/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28088194 0.91 PPARG (0.40) PPARGPPARDPPARAGRM5F10
SCHEMBL28088222 0.88 PPARG (0.37) PPARGPPARDPPARAGRM5F10
SCHEMBL28064060 0.87 LTA4H (0.39) PPARGPPARDPPARAGRM5
SCHEMBL28064163 0.85 ALDH1A1 (0.38) PPARGPPARDPPARAHTR7
SCHEMBL28064069 0.85 PPARG (0.37) PPARGPPARDPPARAGRM5
SCHEMBL28064076 0.83 PPARG (0.47) PPARGPPARDPPARAGRM5CYP1A2
SCHEMBL2229387 0.82 GRM5 (0.46) PPARGPPARDPPARAGRM5CYP1A2
SCHEMBL28064067 0.82 KDM4E (0.40) PPARGPPARDPPARA
SCHEMBL28064102 0.81 KDM4E (0.41) HTR7
SCHEMBL28064084 0.81 TEAD1 (0.47) PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102803258-B Alkyl-heterocyclic carbamate derivatives, their preparation and therapeutic use SAI NUOFEI (FR) 2016-04-20 CN claimed
CN-105837565-A ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION 赛诺菲 2016-08-10 CN disclosed
CN-102803258-B Alkyl-heterocyclic carbamate derivatives, their preparation and therapeutic use SAI NUOFEI (FR) 2016-04-20 CN disclosed